Alaunos Therapeutics, Inc. (TCRT)
$0.79+1.28%Close
SELLCRISIS · day 36
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $2M
- Beta
- -0.97
- P/E (TTM)
- -0.38
- Short % float
- 0.52%
- Days to cover
- 1.0
- SI change
- +60.3%
- 1W
- -3.66%
- 1M
- -49.36%
- vs SPY 1W
- -4.82%
- vs SPY 1M
- -52.35%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on TCRT?
- LOPJLB’s latest quantitative signal on Alaunos Therapeutics, Inc. (TCRT) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is TCRT in?
- Alaunos Therapeutics, Inc. (TCRT) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Alaunos Therapeutics, Inc. (TCRT) do?
- Alaunos Therapeutics, Inc. is an oncology company in the clinical trial phase, specializing in the creation of adoptive T-cell receptor (TCR) engineered therapies. Their pipeline includes a TCR Library, currently undergoing Phase I/II clinical trials, which comprises ten T-cell receptors designed to target mutated KRAS, TP53, and EGFR in various cancers such as non-small cell lung, colorectal, …